The Medicinal Chemistry Division of Medicinal Chemistry of the German Chemical Society (GDCh) awards the Innovation Award for Medicinal / Pharmaceutical Chemistry together with the Pharmaceutical / Medicinal Chemistry Division of the German Pharmaceutical Society (DPhG). The award recognizes outstanding scientific publications and results in the fields of medicinal and pharmaceutical chemistry. Associated with the award are an award certificate and prize money of 5,000 euros donated by the two Divisions . The award usually takes place annually as part of the "Frontiers in Medicinal Chemistry" Conference . The prize can be shared.
The price is currently not advertised.
The Innovation Award 2023 was presented on April 4, 2023 at the Division conference "Frontiers in Medicinal Chemistry 2023" in Vienna
dr Matthew Schiedel awarded "in recognition of his outstanding, original and pioneering research work. By addressing intracellular allosteric binding sites of G protein-coupled receptors, Dr. Schiedel succeeded in developing novel concepts for controlling receptor selectivity and functional selectivity. By applying PROTAC strategies GPCRs could be targeted for proteasomal degradation. The scientific success of his innovative and independent work is impressively documented by publications in internationally renowned journals."
The Innovation Award 2022 was awarded to Dr. Steffen Pockes and Dr. Oliver Thorn-Seshold on March 15, 2022 at the Online Conference "Frontiers in Medicinal Chemistry 2022".
The award goes to Dr. Pockes awarded in recognition of his outstanding, original and pioneering research work. The scientific work of Dr. Pockes deal with the development of novel active substances to combat neurodegenerative diseases. The focus is on innovative ligands for G protein-coupled receptors and selective caspase inhibitors. The scientific success of his innovative and independent research work is documented by publications in the highest-ranking journals of medicinal chemistry.
The award goes to Dr. Thorn-Seshold awarded in recognition of his outstanding, original and pioneering research. dr Thorn-Seshold is developing structurally novel, photoswitchable modulators of the cytoskeleton. This work ranges from basic research to application in vivo. New strategies for tumor therapy are being developed with photoswitchable antimitotics and vascular-damaging agents. The scientific success of his innovative and independent work is documented by publications in the highest-ranking international journals and by the considerable acquisition of third-party funds.
The Innovation Award 2021 was awarded to Prof. Dr. Pierre Koch and Ass.-Prof. Dr. Nina Schützenmeister on the occasion of the Online Conference "Frontiers in Medicinal Chemistry 2021".
The award goes to Prof. Dr. Koch awarded in recognition of his outstanding, original and forward-looking research work. Dr. Koch developed selective kinase inhibitors capable of penetrating the central nervous system. These kinase inhibitors represent an innovative approach to the therapy of neurodegenerative diseases such as Alzheimer's dementia and multiple sclerosis. The scientific success of this innovative research work is documented by numerous publications in respected journals.
The award goes to Prof. Dr. Schützenmeister awarded in recognition of their outstanding, original and forward-looking research work. dr Schützenmeister carried out innovative work on the synthesis of biologically active natural substances. She developed new and efficient synthetic methods and used them to obtain antibacterial and antiviral natural products and natural product analogues. In this way, novel analogues for improving the biological activity become accessible. The scientific success of this innovative and extremely independent research work is documented by publications in respected journals.
The Innovation Award award 2020 was given to PD Dr. Oliver Koch and PD Dr. Daniel Merk forgive.
PD Dr. Oliver Koch in recognition of his excellent, original and forward-looking research. Dr. Koch carried out pioneering work on the development and application of computational methods for the rational molecular design of new biologically active substances. In particular, he dealt with targets for combating mycobacterial infections and for modulating epigenetic processes. The scientific success of this innovative and extremely independent research work is documented in numerous publications in respected journals.
PD Dr. Daniel Merk in recognition of his excellent, original and forward-looking research. Dr. Merk carried out innovative work on the modulation of nuclear receptors. This important class of proteins offers little-known potential new targets for drug development. Dr. Merk used a wide range of methods for his previous research work, which also includes computer-aided methods. In his still young academic career, he has already achieved an astonishing number of high-quality publications.
The Innovation Award award 2019 was given to Dr. Andreas Brunschweiger in recognition of his outstanding, original and pioneering research work on the occasion of the annual conference "Frontiers in Medicinal Chemistry", which developed and synthesized innovative DNA-encoded substance libraries for numerous substance classes. These libraries enable fast and efficient identification of new lead structures in drug research.
|2023||dr Matthias Schiedel, Erlangen-Nuremberg|
|2022|| dr Steffen Pockes, Regensburg|
dr Oliver Thorn-Seshold, Munich
|2021|| dr Pierre Koch, Regensburg|
Ass.-Prof. dr Nina Schützenmeister, Vienna
|2020|| PD dr Oliver Koch, Munster|
PD dr Daniel Merk, Frankfurt
|2019||dr Andreas Brunschweiger, Dortmund|
Prof. Dr. Finn K. Hansen, Leipzig
|2017||Prof. Dr. Anna Katharina Herta Hirsch, Saarbrucken|
dr Andreas Koeberle, Jena
|2015|| dr Nuska Tschammer, Erlangen
dr Peter Kolb, Marburg
|2014||Jun.-Prof. dr Peter Wich, Mainz|
|2013||dr Johanne Notni, Munich|
|2012||dr Christian Ottman, Dortmund|
|2011|| Jun.-Prof. dr Ingo Ott, Brunswick
dr Andreas Bender, Cambridge, UK
|2010||dr Daniel Rauh, Dortmund|
|2008||dr Franz von Nussbaum, Wuppertal|
|2007||Prof. Dr. Christoph Sotriffer, Marburg|
|2006||PD dr Andrea Sinz, Leipzig|
|2005|| PD dr Eric Beitz, Tuebingen
dr Holger Gohlke, Frankfurt
|2003||PD dr Franz F Paintner, Munich|
|2002||dr Jörg Rademann, Tuebingen|
|2001|| dr Andreas Link, Hamburg
dr Wolfgang Sippl, Dusseldorf
|2000||dr Manfred Jung, Munster|
|1999|| PD dr Thomas Carell, Zurich, Switzerland
dr Martin Schlitzer, Marburg
|1998|| Habilitation Prize|
dr Joachim Jose
dr Tanya Schirmeister
This page has been machine translated. If you have any feedback or comments please feel free to contact us.
last modified: 11.04.2023 18:54 H from C.Kniep